|
⚲
|
| Keyboard |
| Vierling John
✚
|
|
|---|---|
| CIK # | 0001191859 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001191859] | |
| 4 | [0001191859] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kinex Pharmaceuticals LLC | |
| Vierling John |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2023-04-21 | Grant | 6,513 | $1.31 | 8,532 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2023-01-13 | Grant | 45,701 | $0.19 | 8,683 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-10-07 | Grant | 35,284 | $0.24 | 8,468 |
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2022-08-03 | Option exercise | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-08-03 | Option exercise | 7,500 | ||
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-07-20 | Grant | 12,772 | $0.67 | 8,557 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2022-06-28 | Grant | 17,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-04-08 | Grant | 11,303 | $0.75 | 8,477 |
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-05-07 | Buy | 250 | $4.50 | 1,125 |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-05-06 | Buy | 1,700 | $4.04 | 6,868 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2020-06-05 | Grant | 12,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-03 | Grant | 2,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-01 | Grant | 10,000 | $0.00 |